1. Begley CM, Gyte GML, Murphy DJ, Devane D, McDonald SJ, McGuire W. Active versus expectant management for women in the third stage of labour. Cochrane Database of Systematic Reviews 2010, Issue 7.
2. Bose P, Regan F, Paterson-Brown S. Improving the accuracy of estimated blood loss at obstetric haemorrhage using clinical reconstructions. BJOG 2006; 113:919-24.
3. Cantwell R, Clutton-Brock T, Cooper G, Dawson A, Drife J, Garrod D, et al. Saving mothers' lives: reviewing maternal deaths to make motherhood safer: 2006-2008. The eighth report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG: an international journal of obstetrics and gynaecology 2011; 118(Suppl 1):1-203.
4. Carroli G, Cuesta C, Abalos E, Glumezoglu AM. Epidemiology of postpartum haemorrhage: a systematic review. Best Practice and Research. Clinical Obstetrics and Gynaecology 2008; 22:999-1012.
5. Chong YS, Su LL. Misoprostol for preventing PPH: somelessonslearned. Lancet 2006; 368:1216-7.
6. Franchini M, Lippi G, Franchi M. The use of recombinant activated factor VII in obstetric and gynaecological haemorrhage. BJOG 2007; 114:8-15.
7. Frenzel D, Condous GS, Papageorghiou AT, McWhinney NA. The use of the 'tamponade test' to stop massive obstetric haemorrhage in placenta accreta. BJOG 2005; 112:676-7.
8. 
AM, Forna F, Villar J, Hofmeyr GJ. Prostaglandins for preventing postpartum haemorrhage. Cochrane Database of Systematic Reviews 2011, Issue 2.
9. Jansen AJ, van Rhenen DJ, Steegers EA, Duvekot JJ. Postpartum haemorrhage and transfusion of blood and blood components. Obstet Gynecol Surv 2005; 60:663-71.
10. Leduc D, Senikas V, Lalonde AB, Ballerman C, Biringer A, Delaney M, et al. Active management of the third stage of labour: prevention and treatment of postpartum hemorrhage. Journal of Obstetrics & Gynaecology Canada: JOGC 2009; 31(10):980-93.
11. Ojala K, Perala J, Kariniemi J, Ranta P, Raudaskoski T, Tekay A. Arterial embolization and prophylactic catheterization for the treatment for severe obstetric hemorrhage. Acta Obstet Gynecol Scand 2005; 84:1075-80.
12. Penney G, Brace V. Nearmissauditinobstetrics. Curr Opin Obstet Gynecol 2007; 19:145-50.
13. Prevention and management of postpartum haemorrage. RCOGGreen-top Guideline, 2007 No. 52.
14. Stainsby D, MacLennan S, Thomas D, Isaac J, Hamilton PJ. Guidelines on the management of massive blood loss. Br J Haematol 2006; 135:634-41.
15. Triopon G, Goron A, Agenor J, Aya GA, Chaillou AL, Begler-Fonnier J, et al. Use of carbetocin in prevention of uterine atony during cesarean section. Comparison with oxytocin [Utilisation de la carbetocine lors de la delivrance dirigee au cours des cesariennes. Comparaison avec l'ocytocine]. Gynecologie, Obstetrique & Fertilite 2010; 38(12):729-34.
16. You WB, Zahn CM. Postpartum haemorrhage: abnormally adherent placenta, uterine inversion, and puerperal haematomas. Clin Obstet Gynecol 2006; 49:184-97.
17. Villar J, Valladares E, Wojdyla D, Zavaleta N, Carroli G, Velazco A, et al. WHO 2005 global survey on maternal and perinatal health research group. Caesarean delivery rates and pregnancy outcomes: the 2005 WHO global survey on maternal and perinatal health in Latin America. Lancet 2006; 367:1819-29.
| Президент Российского общества акушеров-гинекологов академик РАН, профессор | В.Н. Серов |
Согласовано:
| Главный внештатный специалист Министерства здравоохранения Российской Федерации по акушерству и гинекологии академик РАН, профессор | Л.В. Адамян |
